Learn More
PURPOSE We compared the effects of alpha-adrenergic receptor blocker (α-blocker) monotherapy with those of combination therapy with α-blocker and 5-alpha-reductase inhibitor (5-ARI) on benign prostatic hyperplasia (BPH) progression for over 10 years. MATERIALS AND METHODS A total of 620 patients with BPH who received α-blocker monotherapy (α-blocker(More)
  • 1